Back to Market Feed

RELEXXII ER 36 MG TABLET

methylphenidate hydrochloride
$11.9560per EA
High Outlier
DEA Schedule CII

Strength

36 mg/1

NDC

68025009730

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA216117

On Market Since

6/23/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-0.1%

3M

-0.3%

6M

-0.8%

1Y

-0.5%

3Y

N/A

5Y

N/A

All

-0.7%

Generic Alternatives

1 alternative • Same active ingredient

RELEXXII ER 36 MG TABLET
Brand
68025009710•Vertical Pharmaceuticals, LLC
$11.9560

Related Drugs

Same classification

EXCEDRIN EXTRA STRENGTH GELTAB
Brand
00067202124•Haleon US Holdings LLC
$0.1205
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200020•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200024•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200033•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200050•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200077•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200091•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE GELTAB
Brand
00067203520•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203924•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203933•Haleon US Holdings LLC
$0.1338
per EA